A non-interventional study of melphalan flufenamide (melflufen, Pepaxti®) in combination with dexamethasone in patients with relapsed and/or refractory multiple myeloma (RRMM) in Spain, according to the approved label.

Datos básicos

ESTUDIO OBSERVACIONAL OP-115 HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE Año de incio: 2025

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

ONCOPEPTIDES AB

Cita

Compartir